what they said (Hover the mouse cursor over underlined words for more info)

Delayed tumour progression helps glioblastoma multiforme patients live longer

SAN FRANCISCO | A novel vaccine that attacks a protein commonly found on the surface of glioblastoma multiforme (GBM) tumours significantly increases the life expectancy of patients with this disease, according to phase II findings presented at the recent American Association of Neurological Surgeons meeting here.

The study outcomes showed the median time to tumour progression for 23 newly diagnosed GBM patients tested with the vaccine was 12.1 months, which compares favourably with the median time to tumour progression of 6.9 months reported for GBM patients treated with modern chemotherapy and radiation regimens....

The original article can found in the Media Doctor archives.

how did it rate? (more information)

what we said (Hover the mouse cursor over underlined words for more info)

public forum

voice your opinion in the forum

• All comments and feedback submitted to Media Doctor are subject to editorial approval before being made viewable by the public. It may take up to a week for your comments to be approved. Additionally, no response will be given to questions posed in public comments. Media Doctor does not provide medical advice, or answers to medical questions posed by the public.
• If you provide your email address it will not be displayed to the general public.
• Comments may be edited by Media Doctor to remove defamatory or sensitive statements, and brand names.
• Required fields are marked with an asterisk (*).